EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Enterococcus faecium multicenter antimicrobial resistance surveillance in Tunisia (2010-2022): high vancomycin resistance rates and linezolid resistance emergence

Anis Raddaoui, Mouna Louisa Ben Moussa, Yosra Chebbi, Siwar Frigui, Sadok Bougharriou, Lamia Kanzari, Khaoula Meftah, Hajer Battikh, Ons Haddad, Sarra Dhraief, Salma Kaoual, Yassmine Maatouk und 23 weitere

African Health Sciences · 2026 · 26 (2) · 31-37

DOI: 10.4314/ahs.v26i2.5 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift African Health Sciences, 2026. Verfasst von Anis Raddaoui und 34 weiteren Autor:innen. Beteiligte Einrichtung: Service des Laboratoires, Centre National de Greffe de Moelle Osseuse- LR18ES39, Faculté de Tunis, Tunisie. Hauptthemen laut MEDLINE: Enterococcus faecium, Linezolid, Anti-Bacterial Agents, Gram-Positive Bacterial Infections. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vancomycin-resistant Enterococcus faecium is classified among World Health Organization priority pathogens for Research and development of new antibiotics. This study presents the results of 13-year surveillance of antibiotic resistance in E. faecium, with a specific focus on vancomycin and linezolid resistance in thirteen university hospitals across various regions of Tunisia.

Methods

All participating laboratories followed a standardized methodology for clinical sample culture, bacterial identification, antibiotic susceptibility testing according to CA-SFM guidelines, result interpretation, epidemiological data collection. Additionally, they implemented quality controls.

Findings

During the surveillance period, 2,931 E. faecium isolates were collected, predominantly from urine (49.1%) and blood cultures (24%), with high prevalence in Surgery Departments (30.3%) and Intensive Care Units (23.6%). Resistance rates were high for ampicillin (87.1%), erythromycin (93.6%), gentamicin (62.8%) and vancomycin (26%). Since 2019, six linezolid-resistant isolates have been isolated and only one isolate resistant to tigecycline was identified in 2021. Vancomycin resistance had significant upward trend since 2012, peaking at 38.1% in 2017. It was significantly associated to gentamicin (84.9% vs. 53.8%) (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enterococcus faeciumLinezolidAnti-Bacterial AgentsGram-Positive Bacterial InfectionsVancomycin ResistanceHumansTunisiaMicrobial Sensitivity TestsVancomycinDrug Resistance, Bacterial

Stichwörter der Autor:innen

Enterococcus faeciumlinezolid resistancevancomycin resistance

Substanzen

LinezolidAnti-Bacterial AgentsVancomycin

Autor:innen und Institutionen

  • Service des Laboratoires, Centre National de Greffe de Moelle Osseuse- LR18ES39, Faculté de Tunis, Tunisie.
  • Service de Microbiologie, Hôpital Habib Bourguiba, Sfax, Tunisie Université de Sfax, Tunisie.
  • Hôpital Charles Nicole, Laboratoire de Microbiologie, Tunis, Tunisie - Université Tunis El Manar, Laboratoire de recherche, LR99ES09, Faculté de Médecine de Tunis, Tunisie.
  • Service de Microbiologie, Hôpital d'Enfant Bechir Hamza, Tunis, Tunisie.
  • Service de Microbiologie, Hôpital La Rabta, Tunis, Tunisie.
  • Service de Microbiologie, Hôpital Fatouma Bourguiba, Monastir Laboratoire de recherche des maladies transmissibles et substances biologiquement actives LR99ES27, Faculté de pharmacie Université de Monastir, Tunisie.

Zitieren

APA

Raddaoui, A., Moussa, M. L. B., Chebbi, Y., Frigui, S., Bougharriou, S., Kanzari, L., Meftah, K., Battikh, H., Haddad, O., Dhraief, S., Kaoual, S., Maatouk, Y., Dhaou, K. B., Hamdoun, M., Mezghani, S., Mahjoubi, F., Kadri, Y., Marzouk, M., Ghariani, A., …, & Achour, W. (2026). Enterococcus faecium multicenter antimicrobial resistance surveillance in Tunisia (2010-2022): high vancomycin resistance rates and linezolid resistance emergence. African Health Sciences, 26(2), 31-37. https://doi.org/10.4314/ahs.v26i2.5

Vancouver

Raddaoui A, Moussa MLB, Chebbi Y, Frigui S, Bougharriou S, Kanzari L, et al. Enterococcus faecium multicenter antimicrobial resistance surveillance in Tunisia (2010-2022): high vancomycin resistance rates and linezolid resistance emergence. African Health Sciences. 2026;26(2):31-37. doi:10.4314/ahs.v26i2.5

BibTeX
@article{Raddaoui2026,
  author = {Raddaoui, Anis and Moussa, Mouna Louisa Ben and Chebbi, Yosra and Frigui, Siwar and Bougharriou, Sadok and Kanzari, Lamia and Meftah, Khaoula and Battikh, Hajer and Haddad, Ons and Dhraief, Sarra and Kaoual, Salma and Maatouk, Yassmine and Dhaou, Khouloud Ben and Hamdoun, Manel and Mezghani, Senda and Mahjoubi, Faouzia and Kadri, Yosr and Marzouk, M and Ghariani, A and Barguellil, Farouk and Bahri, Olfa and Boukadida, Jalel and Hannachi, Neila and Besbes, Sophia and Thabet, Lamia and Mastouri, Maha and Zribi, Meriem and Smaoui, Hanen and Slim, Leila and Mhiri, Emna and Boubaker, Ilhem Boutiba-Ben and Hammami, Adnene and Karray, Hela and Ouhichi, Ramzi and Achour, Wafa},
  title = {Enterococcus faecium multicenter antimicrobial resistance surveillance in Tunisia (2010-2022): high vancomycin resistance rates and linezolid resistance emergence},
  journal = {African Health Sciences},
  year = {2026},
  volume = {26},
  number = {2},
  pages = {31--37},
  doi = {10.4314/ahs.v26i2.5}
}
Kostenlos starten →